CRCHD Funding for Research and Training

Disparities Research Funding Opportunities

CRCHD provides extramural grants to researchers conducting basic and translational cancer research. Please see the Basic and Translational Disparities Research Funding page and Administrative Supplements to Support Cancer Disparity Collaborative Research page for additional information, deadlines and CRCHD contacts.

• Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
• Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
• Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
• Social Determinants of Health (SDoH) and Quality of Care Contributors to Cancer Disparities in People with HIV (U01 Clinical Trial Optional), RFA pending
• Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)
• Minority Patient-Derived Xenograft (PDX) Development and Trial Centers Network (M-PDTCs) (U54)
• Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (CHD-MH) (U54 Clinical Trial Optional)
• Administrative Supplements to Support Cancer Disparity Collaborative Research (PAR-22-114)

Diversity Training and Biomedical Workforce Development Funding Opportunities

CRCHD offers a continuum of extramural funding opportunities for training and career development. Please see Continuing Umbrella of Research Experiences (CURE), Cancer Moonshot Scholars, and Early Investigator Advancement Program (EIAP) for additional information, deadlines, and CRCHD contacts, or learn about other cancer training opportunities at NCI.

High School & Undergraduate

• Diversity Research Supplements (PA-23-189)

Predoctoral/Graduate

• Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research (F31)
• Diversity Research Supplements (PA-23-189)

Postdoctoral

• Diversity Research Supplements (PA-23-189)
• NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed, K01 Clinical Trial Required)
• NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed, K08 Clinical Trial Required)
• NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed, K22 Clinical Trial Required)
• Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)

Investigator

• Diversity Research Supplements (PA-23-189)
• NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed, K01 Clinical Trial Required)
• NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed, K08 Clinical Trial Required)
• NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed, K22 Clinical Trial Required)
• Exploratory Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
• Cancer Moonshot Scholars program (R01 Clinical Trial Optional)
• Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)

Institutions

• Youth Enjoy Science (YES) Research Education Program (R25 Clinical Trial Not Allowed)

Additional Funding Opportunities

• NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Innovative Programs Funding Opportunities

CRCHD offers the following funding opportunities for accelerating innovative approaches toward eliminating health disparities through diversity training and workforce development, cancer and disparities research, professional development, outreach, education, and mentoring. Please see the Intramural Continuing Umbrella of Research Experiences (iCURE) and Partnerships to Advance Cancer Health Equity (PACHE) pages for additional information, deadlines, and CRCHD contacts.

• Intramural Continuing Umbrella of Research Experiences (iCURE)
• Partnerships to Advance Cancer Health Equity (PACHE)
  • Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
  • Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE)

Community Outreach, Research, and Engagement Funding Opportunities

CRCHD offers funding opportunities for institutions to support engagement, bidirectional communication, and community-engaged cancer disparities research. Please see the Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) and Transformative Educational Advancement and Mentoring Network (TEAM) pages for additional information, deadlines, and CRCHD contacts.

• Transformative Educational Advancement and Mentoring Network (TEAM)
• Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) Program
  • A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional)
  • Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)
• Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network Administrative Supplements Community Health Educator Supplement Program
• Administrative Supplements for the NCI P30 Cancer Center Support Grants for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations

See our fact sheets for additional information about CRCHD programs, initiatives and funding opportunities.